» Articles » PMID: 23137165

Tanshinone IIA Inhibits Metastasis After Palliative Resection of Hepatocellular Carcinoma and Prolongs Survival in Part Via Vascular Normalization

Overview
Journal J Hematol Oncol
Publisher Biomed Central
Specialties Hematology
Oncology
Date 2012 Nov 10
PMID 23137165
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Promotion of endothelial normalization restores tumor oxygenation and obstructs tumor cells invasion, intravasation, and metastasis. We therefore investigated whether a vasoactive drug, tanshinone IIA, could inhibit metastasis by inducing vascular normalization after palliative resection (PR) of hepatocellular carcinoma (HCC).

Methods: A liver orthotopic double-tumor xenograft model in nude mouse was established by implantation of HCCLM3 (high metastatic potential) and HepG2 tumor cells. After removal of one tumor by PR, the effects of tanshinone IIA administration on metastasis, tumor vascularization, and survival were evaluated. Tube formation was examined in mouse tumor-derived endothelial cells (TECs) treated with tanshinone IIA.

Results: PR significantly accelerated residual hepatoma metastases. Tanshinone IIA did not inhibit growth of single-xenotransplanted tumors, but it did reduce the occurrence of metastases. Moreover, it inhibited PR-enhanced metastases and, more importantly, prolonged host survival. Tanshinone IIA alleviated residual tumor hypoxia and suppressed epithelial-mesenchymal transition (EMT) in vivo; however, it did not downregulate hypoxia-inducible factor 1α (HIF-1α) or reverse EMT of tumor cells under hypoxic conditions in vitro. Tanshinone IIA directly strengthened tube formation of TECs, associated with vascular endothelial cell growth factor receptor 1/platelet derived growth factor receptor (VEGFR1/PDGFR) upregulation. Although the microvessel density (MVD) of residual tumor tissue increased after PR, the microvessel integrity (MVI) was still low. While tanshinone IIA did not inhibit MVD, it did dramatically increase MVI, leading to vascular normalization.

Conclusions: Our results demonstrate that tanshinone IIA can inhibit the enhanced HCC metastasis associated with PR. Inhibition results from promoting VEGFR1/PDGFR-related vascular normalization. This application demonstrates the potential clinical benefit of preventing postsurgical recurrence.

Citing Articles

Exploration of ANKRD27 as an immune-related prognostic factor in pan-cancer and hepatocellular carcinoma.

Shen N, Fan C, Ying H, Li X, Zhang W, Yu J Front Oncol. 2025; 14():1511240.

PMID: 39834932 PMC: 11744007. DOI: 10.3389/fonc.2024.1511240.


Homologous-magnetic dual-targeted metal-organic framework to improve the Anti-hepatocellular carcinoma efficacy of PD-1 inhibitor.

Guo H, Li X, Mao D, Wang H, Wei L, Qu D J Nanobiotechnology. 2024; 22(1):206.

PMID: 38658950 PMC: 11044376. DOI: 10.1186/s12951-024-02469-6.


PAK in Pancreatic Cancer-Associated Vasculature: Implications for Therapeutic Response.

Ansardamavandi A, Nikfarjam M, He H Cells. 2023; 12(23).

PMID: 38067120 PMC: 10705971. DOI: 10.3390/cells12232692.


The mechanisms of tanshinone in the treatment of tumors.

Zhang P, Liu W, Wang Y Front Pharmacol. 2023; 14:1282203.

PMID: 37964867 PMC: 10642231. DOI: 10.3389/fphar.2023.1282203.


[Preliminary Study on Microvasculature Normalization Induced by Peritumoral Electroacupuncture in Mice With Breast Cancer Xenografts].

Chang X, Lu T, Huang J Sichuan Da Xue Xue Bao Yi Xue Ban. 2023; 54(5):972-977.

PMID: 37866955 PMC: 10579062. DOI: 10.12182/20230960401.


References
1.
Ebos J, Lee C, Cruz-Munoz W, Bjarnason G, Christensen J, Kerbel R . Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell. 2009; 15(3):232-9. PMC: 4540346. DOI: 10.1016/j.ccr.2009.01.021. View

2.
Wang L, Tang Z, Qin L, Wu X, Sun H, Xue Q . High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential. Hepatology. 2000; 32(1):43-8. DOI: 10.1053/jhep.2000.8525. View

3.
Fisher B, Fisher E . Experimental studies of factors influencing hepatic metastases. III. Effect of surgical trauma with special reference to liver injury. Ann Surg. 1959; 150:731-44. PMC: 1613460. DOI: 10.1097/00000658-195910000-00015. View

4.
Goel S, Duda D, Xu L, Munn L, Boucher Y, Fukumura D . Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev. 2011; 91(3):1071-121. PMC: 3258432. DOI: 10.1152/physrev.00038.2010. View

5.
Huang X, Huang Z, Wang L, Xu Y, Huang X, Ai K . Herbal compound "Songyou Yin" reinforced the ability of interferon-alfa to inhibit the enhanced metastatic potential induced by palliative resection of hepatocellular carcinoma in nude mice. BMC Cancer. 2010; 10:580. PMC: 2976755. DOI: 10.1186/1471-2407-10-580. View